Logo

Novel imaging in non-metastatic castration-resistant prostate cancer (nmCRPC)

Dr. Boris Hadaschik, explains the roles and limitations of novel imaging technologies in non-metastatic castration-resistant prostate cancer. (6:08 min) ►

EM-30317

Læs pligttekst her ERLEADA® (apalutamide)